Holen Sie sich die Stockscreener-App
1.32
7.69%
-0.11
Vorhandelsmarkt:
1.35
0.03
+2.27%
Schlusskurs vom Vortag:
$1.43
Offen:
$1.38
24-Stunden-Volumen:
117.49K
Relative Volume:
0.75
Marktkapitalisierung:
$45.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-14.97
EPS:
-0.0882
Netto-Cashflow:
-
1W Leistung:
-22.35%
1M Leistung:
-19.02%
6M Leistung:
+106.25%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.305
$1.40
1-Wochen-Bereich:
$1.305
$1.81
52-Wochen-Spanne:
$0.51
$19.51
Jupiter Neurosciences Inc Stock (JUNS) Company Profile
Firmenname
Jupiter Neurosciences Inc
Sektor
Branche
Telefon
(561) 406-6154
Adresse
1001 NORTH US HWY 1, JUPITER
Vergleichen Sie JUNS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JUNS
Jupiter Neurosciences Inc
|
1.32 | 49.81M | 0 | 0 | 0 | -0.0882 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Jupiter Neurosciences Inc Aktie (JUNS) Neueste Nachrichten
How buybacks impact Jupiter Neurosciences Inc. stock valueJuly 2025 Momentum & AI Powered Buy and Sell Recommendations - newser.com
Why hedge funds are buying Jupiter Neurosciences Inc. stockJuly 2025 Decliners & Verified Momentum Stock Ideas - newser.com
What insider trading reveals about Jupiter Neurosciences Inc. stockTrade Entry Summary & Long Hold Capital Preservation Tips - newser.com
Is Jupiter Neurosciences Inc. stock overvalued by current metricsBreakout Watch & Verified Momentum Stock Alerts - newser.com
Does Jupiter Neurosciences Inc. fit your quant trading modelMarket Sentiment Review & Safe Capital Allocation Plans - newser.com
Strategies to average down on Jupiter Neurosciences Inc.July 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com
Will Jupiter Neurosciences Inc. stock continue dividend increases2025 EndofYear Setup & Growth Focused Stock Pick Reports - newser.com
Backtesting results for Jupiter Neurosciences Inc. trading strategiesQuarterly Trade Summary & Verified Short-Term Plans - newser.com
Tick level data insight on Jupiter Neurosciences Inc. volatilityLayoff News & Verified Momentum Stock Alerts - newser.com
Published on: 2025-11-03 01:15:08 - newser.com
Sentiment analysis tools applied to Jupiter Neurosciences Inc.IPO Watch & Low Risk Investment Opportunities - newser.com
Why Jupiter Neurosciences Inc. stock is a value investor pickTrade Ideas & Long-Term Investment Growth Plans - newser.com
Why Jupiter Neurosciences Inc. stock could be next big winner2025 Investor Takeaways & Real-Time Sentiment Analysis - newser.com
How to recover losses in Jupiter Neurosciences Inc. stockPortfolio Value Summary & Short-Term Swing Trade Alerts - newser.com
Analyzing Jupiter Neurosciences Inc. with risk reward ratio chartsPortfolio Risk Report & Fast Exit and Entry Trade Guides - newser.com
Applying big data sentiment scoring on Jupiter Neurosciences Inc.July 2025 Spike Watch & Technical Pattern Based Buy Signals - newser.com
Can you recover from losses in Jupiter Neurosciences Inc.2025 Momentum Check & Low Drawdown Trading Strategies - newser.com
Smart tools for monitoring Jupiter Neurosciences Inc.’s price actionWeekly Market Outlook & Daily Volume Surge Trade Alerts - newser.com
Published on: 2025-11-02 13:42:03 - newser.com
Is Jupiter Neurosciences Inc. stock supported by strong fundamentals2025 Breakouts & Breakdowns & Fast Gain Swing Trade Alerts - newser.com
Is Jupiter Neurosciences Inc. stock safe for conservative investorsJobs Report & Free Fast Entry Momentum Trade Alerts - newser.com
Is Jupiter Neurosciences Inc. stock attractive for ETFsMarket Growth Review & Weekly Market Pulse Alerts - newser.com
What risks investors should watch in Jupiter Neurosciences Inc. stockJuly 2025 EndofMonth & Reliable Trade Execution Plans - newser.com
Published on: 2025-10-31 05:25:20 - newser.com
Finanzdaten der Jupiter Neurosciences Inc-Aktie (JUNS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):